“Automation and Digital Integration in TB Diagnostics”
- A key trend in the IGRA market is the increasing adoption of automated and digitally integrated platforms to improve test accuracy, efficiency, and scalability in tuberculosis (TB) diagnostics
- These innovations streamline laboratory workflows by minimizing manual intervention, reducing the risk of human error, and enhancing consistency in IGRA test results
- For instance, platforms such as QIAGEN’s QuantiFERON-TB Gold Plus now support automation-compatible workflows with LIS connectivity and automated ELISA processing, significantly improving throughput in high-demand settings
- The integration of automation and digital tools is transforming TB testing, enabling broader screening initiatives, accelerating result turnaround times, and driving demand for advanced IGRA solutions globally
